The price of Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) closed at $3.56 in the last session, up 0.42% from day before closing price of $3.54. In other words, the price has increased by $+0.0150 from its previous closing price. On the day, 644156 shares were traded. MNMD stock price reached its highest trading level at $3.6950 during the session, while it also had its lowest trading level at $3.4950.
We take a closer look at MNMD’s different ratios to gain a better understanding of the stock.
Upgrades & Downgrades
On November 16, 2022, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $5.
On August 26, 2022, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $3.50.Oppenheimer initiated its Outperform rating on August 26, 2022, with a $3.50 target price.
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 21 when Barrow Robert sold 3,861 shares for $2.69 per share. The transaction valued at 10,386 led to the insider holds 247,232 shares of the business.
Karlin Dan sold 1,211 shares of MNMD for $3,258 on Dec 21. The Chief Medical Officer now owns 264,082 shares after completing the transaction at $2.69 per share. On Oct 27, another insider, Karlin Dan, who serves as the Chief Medical Officer of the company, sold 644 shares for $3.00 each. As a result, the insider received 1,932 and left with 265,293 shares of the company.
Stock Price History:
Over the past 52 weeks, MNMD has reached a high of $22.20, while it has fallen to a 52-week low of $2.12. The 50-Day Moving Average of the stock is 2.7333, while the 200-Day Moving Average is calculated to be 7.8986.
According to the various share statistics, MNMD traded on average about 611.88K shares per day over the past 3-months and 776.89k shares per day over the past 10 days. A total of 37.57M shares are outstanding, with a floating share count of 32.93M. Insiders hold about 12.20% of the company’s shares, while institutions hold 14.93% stake in the company. Shares short for MNMD as of Oct 13, 2022 were 1M with a Short Ratio of 2.28M, compared to 963.78k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 2.82% and a Short% of Float of 2.84%.
The company has 5 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.6 for the current quarter, with a high estimate of -$0.55 and a low estimate of -$0.63, while EPS last year was -$0.9. The consensus estimate for the next quarter is -$0.59, with high estimates of -$0.44 and low estimates of -$0.67.
Analysts are recommending an EPS of between -$0.3 and -$2.56 for the fiscal current year, implying an average EPS of -$2. EPS for the following year is -$2.42, with 6 analysts recommending between -$2.06 and -$3.